Anti-Toxoplasma gondii antibodies in pregnant women and their newborn infants in the region of são jose ́ do rio preto, São Paulo, Brazil;Anticorpos anti-Toxoplasma gondii em gestantes e seus neonatos na região de são jose ́ do rio preto, São Paulo, Brazil

Sao Paulo Medical Journal

Volumn 129, Issue 4, 2011, Pages 261-266

  de Mattos, Cinara de Cássia Brandão ^a   Spegiorin, Lígia Cosentino Junqueira Franco ^a   Meirai, Cristina da Silva ^a   Silva, Thaís da Costa ^a   Ferreira, Ana Iara da Costa ^a   Nakashima, Fabiana ^a   Pereira Chioccola, Vera Lúcia ^a,b   de Mattos, Luiz Carlos ^a,b  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

High risk; Neonatal screening; Pregnancy; Prenatal diagnosis; Serologic tests; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BRAZIL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATION PERIOD; HIGH RISK PREGNANCY; HUMAN; IMMUNOFLUORESCENCE TEST; INFANT; MAJOR CLINICAL STUDY; MATERNAL SERUM; NEWBORN; OUTPATIENT DEPARTMENT; PARASITE TRANSMISSION; PREGNANT WOMAN; THIRD TRIMESTER PREGNANCY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANTIBODIES, PROTOZOAN; ANTIBODY AFFINITY; BRAZIL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; PREGNANCY; RISK FACTORS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 80053453506     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802011000400010     Document Type: Article

References (30)

1. rd ed. Oxford: Elservier; 2009. p.732-43.
2. Munoz M, Liesenfeld O, Heimesaat MM. Immunology of Toxoplasma gondii. Immunol Rev. 2011;240(1):269-85.
3. Hill D, Dubey J P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002;8(10):634-40.
4. Kaye A. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants. Journal of Pediatric Health Care. Available from: http://www.jpedhc.org/article/S0891-5245(10)00095-7/abstract. Accessed in 2011 (Mar 18).
5. Dunn D, Wallon M, Peyron F, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353(9167):1829-33.
6. Raeber PA, Berger R, Biedermann K, et al. La prévention de la toxoplasmose congénitale en Suisse. Texte de consensus du Groupe de travail "Toxoplasmose congénitale" de l'Ofce fédéral de la santé publique [Prevention of congenital toxoplasmosis in Switzerland. Consensus report of the study group "Congenital toxoplasmosis" of the federal public health ofce]. Schweiz Med Wochenschr Suppl. 1995;65:113S-120S.
7. Hohlfeld P, Dafos F, Thulliez P, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr. 1989;115(5 Pt 1):765-9.
8. Romand S, Chosson M, Franck J, et al. Usefulness of quantitative polymerase chain reaction in amniotic fuid as early prognostic marker of fetal infection with Toxoplasma gondii. Am J Obstet Gynecol. 2004;190(3):797-802.
9. Peyron F, Lobry JR, Musset K, et al. Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America). Microbes Infect. 2006;8(9-10):2333-40.
10. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39(12):1385-94.
11. Avelino MM, Campos D Jr, Parada JB, Castro AM. Risk factors for Toxoplasma gondii infection in women of childbearing age. Braz J Infect Dis. 2004;8(2):164-74.
12. Carmo ACZ, Bottom SR, Fleck J, Beck ST. Importância do rastreamento pré-concepcional e pré-natal da infecção por T. gondii; prevalência sorológica em um hospital público [The importance of screening preconception and antenatal T. gondii infection serological prevalence in a public hospital]. Rev Bras Anal Clin. 2005;37(1):49-52.
13. Castilho-Pelloso M P, Falavigna DLM, Araújo SM, Falavigna-Guilherme AL. Monitoramento de gestantes com toxoplasmose em serviços públicos de saúde [Monitoring of pregnant women with toxoplasmosis in public health services]. Rev Soc Bras Med Trop. 2005;38(6):532-3.
14. Reis MM, Tessaro MM, D'Azevedo PA. Toxoplasma-IgM and IgG-avidity in single samples from areas with a high infection rate can determine the risk of mother-to-child transmission. Rev Inst Med Trop São Paulo. 2006;48(2):93-8.
15. Carellos EVM, Andrade GMQ, Aguiar RALP. Avaliação da aplicação do protocolo de triagem pré-natal para toxoplasmose em Belo Horizonte, Minas Gerais, Brasil: estudo transversal em puérperas de duas maternidades [Evaluation of prenatal screening for toxoplasmosis in Belo Horizonte, Minas Gerais State, Brazil: a cross-sectional study of postpartum women in two maternity hospitals]. Cad Saúde Pública = Rep Public Health. 2008;24(2):391-401.
16. Lago EG, Carvalho RL, Jungblut R, Silva VB, Fiori RM. Screening for Toxoplasma gondii antibodies in 2,513 consecutive parturient women and evaluation of newborn infants at risk for congenital toxoplasmosis [Triagem para anticorposanti-Toxoplasma gondii em 2. 513 parturientes consecutivas e avaliação dos recém-nascidos com risco de toxoplasmose congênita]. Sci Med. 2009;19(1):27-34.
17. Lago EG, Neto EC, Melamed J, et al. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery. Paediatr Perinat Epidemiol. 2007;21(6):525-31.
18. Prefeitura Municipal de São José do Rio Preto. Secretaria de Planejamento e Gestão Estratégica. Setor de Estudos Socieconômicos. Conjuntura Econômica de São José do Rio Preto 2009. Available from: http://www.riopreto.sp.gov.br/PortalGOV/do/subportais_Show?c=146. Accessed in 2011 (Mar 4).
19. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Ações Programáticas Estratégicas. Área Técnica de Saúde da Mulher. Pré-natal e puerpério: atenção qualifcada e humanizada - manual técnico. Brasilia: Ministério da Saúde; 2005. Available from: http://portal.saude.gov.br/portal/arquivos/pdf/manual_puerperio_2006.pdf. Accessed in 2011 (Mar 4).
20. Mattos CCB, Cintra JR, Ferreira AIC, et al. Lack of association between ABO histo-blood groups, secretor and non-secretor phenotypes, and anti-Toxoplasma gondii antibodies among pregnant women from the northwestern region of Sao Paulo State, Brazil. Archives of Medical Science. 2008;4(3):254-8. Available from: http://www.termedia.pl/Journal/-19/Streszczenie-11195. Accessed in 2011 (Mar 4).
21. Meira CS, Costa-Silva TA, Vidal JE, et al. Use of the serum reactivity against Toxoplasma gondii excreted-secreted antigens in cerebral toxoplasmosis diagnosis in human immunodefciency virus-infected patients. J Med Microbiol. 2008;57(Pt 7):845-50.
22. Colombo FA, Vidal JE, Penalva de Oliveira AC, et al. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J Clin Microbiol. 2005;43(10):5044-7.
23. Gonçalves MA, Matos CCB, Spegiorin LC, et al. Seropositivity rates for toxoplasmosis, rubella, syphilis, cytomegalovirus, hepatitis and HIV among pregnant women receiving care at a public health service, São Paulo State, Brazil. Braz J Infect Dis. 2010;14(6):601-5.
24. Spalding SM, Amendoeira MRR, Klein CH, Ribeiro LC. Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil. Rev Soc Bras Med Trop. 2005;38(2):173-7.
25. Vaz AJ, Guerra EM, Ferratto LCC, Toledo LAS, Azevedo Neto RS. Sorologia positiva para síflis, toxoplasmose e doença de Chagas em gestantes de primeira consulta em centros de sáude da área metropolitana, Brasil [Positive serology of syphilis, toxoplasmosis and Chagas' disease in pregnant women in their frst visit to state health centres in a metropolitan area, Brazil]. Rev Saúde Pública. 1990;24(5):373-9.
26. Cerqueira RL, Kawarabayashi M, Guimarães AC, et al. Santo Inácio revisited: protozoan diseases in an isolated village in northeastern Brazil after twenty years. Am J Trop Med Hyg. 1998;59(5):736-40.
27. Rey LC, Ramalho ILC. Seroprevalence of toxoplasmosis in Fortaleza, Ceara, Brazil. Rev Inst Med Trop São Paulo. 1999;41(3):171-4.
28. Figueiró-Filho EA, Senefonte FRA, Lopes AHA, et al. Freqüência das infecções pelo HIV-1, rubéola, síflis, toxoplasmose, citomegalovírus, herpes simples, hepatite B, hepatite C, doença de Chagas e HTLV I/II em gestantes, do Estado do Mato Grosso do Sul [Frequency of HIV-1, rubella, syphilis, toxoplasmosis, cytomegalovirus, simple herpes virus, hepatitis B, hepatitis C, Chagas disease and HTLV I/II infection in pregnant women of State of Mato Grosso do Sul]. Rev Soc Bras Med Trop. 2007;40(2):181-7.
29. Figueiró-Filho EA, Nanni Junior C, Almeida GB, et al. Toxoplasmose aguda: revisão de métodos diagnósticos baseada em evidências e proposta de protocolo de seguimento durante a gestação [Acute toxoplasmosis: a review of diagnostic methods based in evidences and a proposal of management during pregnancy]. Femina. 2007;35(111):723-9.
30. Petersen E, Pollack A, Reiter-Owona I. Recent trends in research on congenital toxoplasmosis. Int J Parasitol. 2001;31(2):115-44.